OSAM
AVXL icon

O'Shaughnessy Asset Management’s Anavex Life Sciences AVXL Stock Holding History

O'Shaughnessy Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,332
Closed -$196K – 1281
2021
Q4 		$196K Buy
11,332
+7,000
+162% +$133K ﹤0.01% 1060
2021
Q3 		$78K Sell
4,332
-3,468
-44% -$69K ﹤0.01% 1472
2021
Q2 		$178K Hold
7,800
– – ﹤0.01% 1083
2021
Q1 		$117K Buy
7,800
+7,799
+779,900% +$85.2K ﹤0.01% 1131
2020
Q4 		$0 Hold
1
– – ﹤0.01% 2073
2020
Q3 		$0 Hold
1
– – ﹤0.01% 1869
2020
Q2 		$0 Hold
1
– – ﹤0.01% 1729
2020
Q1 		$0 Hold
1
– – ﹤0.01% 1328
2019
Q4 		$0 Buy
+1
New +$3 ﹤0.01% 1816

Other funds holding AVXL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return